New Delhi, Dec 30: Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. The approval granted by the US Food and Drug Administration (USFDA) to Granules Pharmaceuticals, Inc (GPI), a wholly-owned arm, is for the abbreviated new drug application (ANDA) of amphetamine mixed salts of strengths 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg immediate release […]
Related Keywords
Virginia , United States , New Delhi , Delhi , India , Priyanka Chigurupati , Teva Women Health Inc , Granules Pharmaceuticals Inc , Drug Administration , Granules India Ltd On , Granules India Ltd , Attention Deficit Hyperactivity Disorder , Granules Pharmaceuticals , Teva Women , Health Inc ,
comparemela.com © 2020. All Rights Reserved.